Novavax | NVAX - Ativo Circulante





Ativo Circulante Alterar Data
Adma Biologics USD 528.2M 17.03M 2026-06
Agenus USD 78.81M 16.47M 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
Cassava Sciences USD 87.96M 9.74M 2026-03
Geron USD 486.34M 12.19M 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
MannKind USD 245.71M 5.45M 2026-06
Merck USD 36.68B 1.66B 2026-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Moderna USD 5.82B 45M 2026-06
Novartis USD 26.61B 3.85B 2026-03
Novavax USD 771.1M 79.72M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
TG Therapeutics USD 1.15B 58.72M 2026-06